Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by SERPINA1 gene mutations, leading to conditions like pulmonary emphysema and liver dysfunction. The AATD market is in its ...
Alpha-1 antitrypsin deficiency, AATD, is an inherited disease affecting the lung, liver, and, rarely, skin. Alpha-1 antitrypsin, AAT, is a protease inhibitor of the proteolytic enzyme elastase.
Edward M. Kaye, MD, CEO and Director of Stoke Therapeutics. For decades, Adrian Krainer, professor at Cold Spring Harbor Laboratory (CSHL), has studied the mechanisms of RNA splicing, how they go awry ...
Korro Bio is a biotech company focused on developing RNA editing technology to treat genetic conditions, specifically alpha-1 antitrypsin deficiency. Their most advanced program, KRRO-110, aims to ...
(MENAFN- GlobeNewsWire - Nasdaq) Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by SERPINA1 gene mutations, leading to conditions like pulmonary emphysema and liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results